AGP Picks
View all

Endometriosis linked to higher type 2 diabetes risk in largest study to date

Aug. 10, 2026
By AI, Created 13:33 UTC, Aug 10, 2026, AGP -

Women with endometriosis had a 46% higher risk of type 2 diabetes in a new study from George Mason University researchers and collaborators. The findings, based on nearly 3 million women over 25 years, suggest the condition may carry broader long-term health risks and could support earlier screening for some patients.

Why it matters: - Endometriosis affects about 1 in 10 women of reproductive age. - The condition is already tied to chronic pelvic pain, infertility and other complications. - If the findings hold up, clinicians may be able to spot women with endometriosis who face higher diabetes risk and could benefit from earlier screening or prevention.

What happened: - Researchers led by George Mason College of Public Health studied the relationship between endometriosis and type 2 diabetes. - The study found women with endometriosis had a 46% higher risk of developing type 2 diabetes than women without the condition. - The research was published in Diabetologia. - Maggie Fuzak Nunziato, a George Mason doctoral student in epidemiology, led the study with Anna Pollack, professor of Global and Community Health. - The study examined health records from nearly 3 million women over 25 years.

The details: - The data came from the Utah Population Database and covered 1996 to 2021. - Nearly 100,000 women in the study had a diagnosis of endometriosis. - Risk varied by form of endometriosis, which suggests the condition may have broader long-term health effects than previously recognized. - The strongest association with diabetes appeared among women with extra-pelvic endometriosis, where disease is found outside the pelvis. - The association was strongest among premenopausal women and women without obesity. - The researchers said chronic inflammation linked to endometriosis may affect metabolic health, but more research is needed. - The study included collaborators from the University of Utah, the University of Arizona, Brigham and Women's Hospital and Intermountain Health.

Between the lines: - Earlier studies often treated endometriosis as a single condition and generally found little or no overall link to type 2 diabetes. - This study suggests subtypes of endometriosis may matter more than the diagnosis alone. - The pattern in premenopausal women and women without obesity is notable because those groups are not usually considered the highest-risk groups for type 2 diabetes. - The findings show an association, not proof that endometriosis causes diabetes.

What's next: - Researchers want more studies to clarify the biological mechanism connecting the two conditions. - Further research could test whether earlier metabolic screening improves outcomes for women with endometriosis. - Future work may also determine which patients face the highest risk and should be prioritized for prevention efforts.

The bottom line: - Endometriosis may be a marker for higher long-term metabolic risk, not just a reproductive health condition.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

From K Through College

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

From K Through College

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.